Detalhe da pesquisa
1.
Instrumented Trail-Making Task to Differentiate Persons with No Cognitive Impairment, Amnestic Mild Cognitive Impairment, and Alzheimer Disease: A Proof of Concept Study.
Gerontology
; 63(2): 189-200, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27855415
2.
Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.
Alzheimers Dement
; 11(8): 994-1004, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25849033
3.
PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders.
BMC Neurol
; 14: 79, 2014 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-24716655
4.
Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies.
J Alzheimers Dis
; 80(4): 1603-1612, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33720879
5.
Probable early-onset Alzheimer's disease in an apolipoprotein E2 homozygote.
Dement Geriatr Cogn Disord
; 30(5): 387-91, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20975270
6.
Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort.
Neurodegener Dis
; 7(1-3): 183-6, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20224282
7.
Reduced risk of incident AD with elective statin use in a clinical trial cohort.
Curr Alzheimer Res
; 5(4): 416-21, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18690839
8.
Neuropathological and biochemical assessments of an Alzheimer's disease patient treated with the γ-secretase inhibitor semagacestat.
Am J Neurodegener Dis
; 3(3): 115-33, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25628963
9.
Bapineuzumab alters aß composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapy.
PLoS One
; 8(3): e59735, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23555764
10.
Tau is reduced in AD plasma and validation of employed ELISA methods.
Am J Neurodegener Dis
; 1(1): 99-106, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23383382
11.
Positron emission tomography and neuropathologic estimates of fibrillar amyloid-ß in a patient with Down syndrome and Alzheimer disease.
Arch Neurol
; 68(11): 1461-6, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22084131